{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T19:39:00Z","timestamp":1776195540368,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.ejphar.2008.07.036","type":"journal-article","created":{"date-parts":[[2008,7,31]],"date-time":"2008-07-31T13:00:25Z","timestamp":1217509225000},"page":"65-68","source":"Crossref","is-referenced-by-count":8,"title":["Influence of combinations of acetylsalicylic acid, acetaminophen, and diclofenac on platelet aggregation"],"prefix":"10.1016","volume":"595","author":[{"given":"Katja S.","family":"Galliard-Grigioni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Fehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter H.","family":"Reinhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2008.07.036_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1161\/01.STR.0000106763.46123.F6","article-title":"Antiplatelet effect of aspirin in patients with cerebrovascular disease","volume":"35","author":"Alberts","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2008.07.036_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative metaanalysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Antithrombotic Trialist's Collaboration","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.ejphar.2008.07.036_bib3","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/j.1365-2044.2004.03907.x","article-title":"Effect of non-selective, non-steroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors on the PFA-100 closure time","volume":"59","author":"Blaicher","year":"2004","journal-title":"Anaesthesia"},{"key":"10.1016\/j.ejphar.2008.07.036_bib4","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis","volume":"343","author":"Bombardier","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2008.07.036_bib5","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","article-title":"Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial","volume":"352","author":"Bresalier","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2008.07.036_bib6","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa003199","article-title":"Cyclooxygenase inhibitors and the antiplatelet effects of aspirin","volume":"345","author":"Catella-Lawson","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2008.07.036_bib7","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1161\/CIRCULATIONAHA.105.595793","article-title":"Nonsteroidal anti-inflammatory drugs, acetaminophen, and the risk of cardiovascular events","volume":"113","author":"Chan","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2008.07.036_bib8","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3109\/09537109909169175","article-title":"Can the Platelet Function Analyzer (PFA)-100 test substitute for the template bleeding time in routine clinical practice?","volume":"10","author":"Francis","year":"1999","journal-title":"Platelets"},{"key":"10.1016\/j.ejphar.2008.07.036_bib9","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1136\/bmj.330.7504.1366","article-title":"Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis","volume":"330","author":"Hippisley-Cox","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.ejphar.2008.07.036_bib10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0828-282X(07)70744-4","article-title":"The effect of acetylsalicylic acid resistance on prognosis of patients who have developed acute coronary syndrome during acetylsalicylic acid therapy","volume":"23","author":"Hobikoglu","year":"2007","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ejphar.2008.07.036_bib11","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/bmj.332.7553.1302","article-title":"Do selective cyclo-oxygenase-2 inhibitors and traditional anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomized trials","volume":"332","author":"Kearney","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.ejphar.2008.07.036_bib12","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1161\/01.CIR.0000087593.07533.9B","article-title":"Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal anti-inflammatory drugs","volume":"108","author":"Kurth","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2008.07.036_bib13","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0049-3848(89)90150-3","article-title":"Inhibition of human platelet function in vitro and ex vivo by acetaminophen","volume":"53","author":"Lages","year":"1989","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ejphar.2008.07.036_bib14","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/0090-6980(82)90123-X","article-title":"Indomethacin prevents the long-lasting inhibitory effect of aspirin on human platelet cyclo-oxygenase activity","volume":"23","author":"Livio","year":"1982","journal-title":"Prostaglandins"},{"key":"10.1016\/j.ejphar.2008.07.036_bib15","doi-asserted-by":"crossref","first-page":"7330","DOI":"10.1021\/bi952776w","article-title":"Synthesis and use of iodinated nonsteroidal antiinflammatory drug analogs as crystallographic probes of the prostaglandin H2 synthase cyclooxygenase active site","volume":"35","author":"Loll","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejphar.2008.07.036_bib16","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(03)12509-3","article-title":"Effect of ibuprofen on cardioprotective effect of aspirin","volume":"361","author":"MacDonald","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2008.07.036_bib17","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1001\/jama.296.13.jrv60011","article-title":"Cardiovascular risk and inhibition of cyclooxygenase. A systematic review of the observational studies of selective and nonselective inhibitions of cyclooxygenase 2","volume":"296","author":"McGettigan","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2008.07.036_bib18","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1096\/fj.06-6615com","article-title":"Stronger inhibition by nonsteroid anti-inflammatory drugs of cyclooxygenase-1 in endothelial cells than platelets offers an explanation for increased risk of thrombotic events","volume":"20","author":"Mitchell","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2008.07.036_bib19","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/bja\/aeg195","article-title":"Propacetamol augments inhibition of platelet function by diclofenac in volunteers","volume":"91","author":"Munsterhjelm","year":"2003","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ejphar.2008.07.036_bib20","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1399-6576.2005.00707.x","article-title":"Characterization of inhibition of platelet function by paracetamol and its interaction with diclofenac in vitro","volume":"49","author":"Munsterhjelm","year":"2005","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.ejphar.2008.07.036_bib21","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/bja\/ael108","article-title":"Influence on platelet aggregation of i.v. parecoxib and acetaminophen in healthy volunteers","volume":"97","author":"Munsterhjelm","year":"2006","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ejphar.2008.07.036_bib22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11239-006-8952-4","article-title":"The role of aspirin resistance on outcome in patients with acute coronary syndrome and the effect of clopidogrel therapy in the prevention of major cardiovascular events","volume":"22","author":"Pamukcu","year":"2006","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.ejphar.2008.07.036_bib23","doi-asserted-by":"crossref","first-page":"234S","DOI":"10.1378\/chest.126.3_suppl.234S","article-title":"Platelet-active drugs: the relationship among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Patrono","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.ejphar.2008.07.036_bib24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/abbi.2000.2232","article-title":"Mechanism of acetaminophen inhibition of cyclooxygenase isoforms","volume":"387","author":"Quellet","year":"2001","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2008.07.036_bib25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0262-1746(82)90076-2","article-title":"Effect of acetaminophen and salicylate on aspirin-induced inhibition of human platelet cyclo-oxygenase","volume":"9","author":"Rao","year":"1982","journal-title":"Prostaglandins Leukot. Med."},{"key":"10.1016\/j.ejphar.2008.07.036_bib26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1161\/01.ATV.3.4.383","article-title":"Ibuprofen protects platelet cyclooxygenase from irreversible inhibition by aspirin","volume":"3","author":"Rao","year":"1983","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.ejphar.2008.07.036_bib27","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/sj.bjp.0705078","article-title":"Effects of acetaminophen on constitutive and inducible prostanoid biosynthesis in human blood cells","volume":"138","author":"Sciulli","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.07.036_bib28","first-page":"443","article-title":"Evaluation of a Platelet Function Analyzer in patients with a bleeding tendency","volume":"132","author":"Wuillemin","year":"2002","journal-title":"Swiss Med. Wkly."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908007917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908007917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,26]],"date-time":"2018-12-26T22:26:18Z","timestamp":1545863178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299908007917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":28,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0014299908007917"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2008.07.036","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}